Flyers' Oskar Lindblom has Ewing's sarcoma cancer, is expected to miss rest of season

Sam Carchidi and Marie McCullough, The Philadelphia Inquirer on

Published in Hockey

ST. PAUL, Minn. -- Flyers left winger Oskar Lindblom has a rare medical condition and is expected to miss the rest of the season, the team announced on Friday.

Lindblom, 23, has been diagnosed with Ewing's sarcoma by leading specialists at the University of Pennsylvania, Flyers general manager Chuck Fletcher said.

"The Flyers will do everything possible to support Oskar and assist him in securing the best care possible," Fletcher said in a statement.

Ewing's sarcoma is a very rare cancerous tumor that grows in the bones or the soft tissue around the bones. It usually affects people from the ages of 10 to 20. About 250 children and young adults are diagnosed every year in the United States -- slightly more males than females, and most of them white.

The cancer is treated with chemotherapy, surgery and radiation. If it hasn't spread beyond the site of origin, the cure rates are near 80 percent. It can spread to the lungs, other bones and bone marrow, so chemotherapy is important to kill micrometastases.

Fletcher said that "out of respect to Oskar and his family" the team would have no further comment at his time.


The hockey world, and beyond, showed their support on social media.

Tweeted Derek Settlemyre, the Flyers' equipment manager: "We are fighting with our brother @oskarlindblom We love you bro!"

"Together we are OskarStrong," the Flyers tweeted.

Many opposing players and teams also showed Lindblom their support on social media.


swipe to next page


blog comments powered by Disqus